Panfeng Shang
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Lateral Transperitoneal Versus Posterior Retroperitoneoscopic Adrenalectomy for Adrenal Tumors: A Randomized Controlled Trial.
Journal: Journal of endourology
Published: August 05, 2026
Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance.
Journal: BJU international
Published: June 01, 2026
Comment on 'Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach'.
Journal: BJU international
Published: April 23, 2026
Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study.
Journal: Frontiers in immunology
Published: February 11, 2026
Commentary: Association of composite dietary antioxidant index with high risk of prostate cancer in middle-aged and elderly men: insights from NHANES.
Journal: Frontiers in immunology
Published: January 29, 2026
Angiogenesis-Informed Preoperative CT Radiogenomics Predicts Overall Survival in Clear Cell Renal Cell Carcinoma: Development and External Validation.
Journal: Cancers
Published: January 23, 2026
TREM2 in Urological Malignancies and Benign Lesions: Mechanistic Convergence, Functional Heterogeneity, and Translational Perspectives: A Narrative Review.
Journal: Cancers
Published: December 24, 2025
Efficacy analysis of transurethral en bloc resection for bladder tumors ≥3 cm.
Journal: Translational andrology and urology
Published: December 20, 2025
CCT5 as a candidate biomarker in bladder cancer: functional validation and mechanistic clues.
Journal: American journal of cancer research
Published: October 05, 2025
Commentary: Higher blood manganese level associated with increased risk of adult latent tuberculosis infection in the US population.
Journal: Frontiers in public health
Published: September 16, 2025
Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective study.
Journal: Frontiers in immunology
Published: September 05, 2025
Last Updated: 09/26/2026